Terminated/Withdrawn

Bacterial Infection

Bayer Identifier:

Trial_1370

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study of oral Ciprofloxacin versus Tobramycin plus Ceftazidime in the treatment of children and juveniles suffering from acute pulmonary exacerbation of cystic fibrosis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

5 - 17 Years

Trial summary

Enrollment Goal

108

Trial Dates

February 1993 - May 1995

Phase

Phase 3

Could I Receive a placebo

N/A

Products

Cipro (Ciprofloxacin hydrochloride, BAYO9867)

Accepts Healthy Volunteer

N/A

Trial design

Prospective, randomized, non-blind, multi-center comparative safety and efficacy study of oral Ciprofloxacin versus Tobramycin plus Ceftazidime in the treatment of children and juveniles suffering from acute pulmonary exacerbation of cystic fibrosis

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.